Ron Frieson

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Carolyn Rucci, attorney-in-fact for Ronald E. Frieson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ron Frieson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. Director Common Stock 129,500 $339,290 $2.62 10 Jun 2025 Direct
Akebia Therapeutics, Inc. Director Stock Option (Right to buy) 53,600 10 Jun 2025 Direct

Insider Reports Filed by Ron Frieson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKBA Akebia Therapeutics, Inc. 10 Jun 2025 2 $0 4 Director 11 Jun 2025, 17:13
AKBA Akebia Therapeutics, Inc. 17 Jan 2025 2 +$9,045 4 Director 22 Jan 2025, 16:06
AKBA Akebia Therapeutics, Inc. 06 Jun 2024 2 $0 4 Director 10 Jun 2024, 16:19
AKBA Akebia Therapeutics, Inc. 06 Jun 2023 2 $0 4 Director 08 Jun 2023, 16:07
AKBA Akebia Therapeutics, Inc. 08 Jun 2022 2 $0 4 Director 09 Jun 2022, 16:57
AKBA Akebia Therapeutics, Inc. 01 Nov 2021 1 $0 4 Director 03 Nov 2021, 16:47
AKBA Akebia Therapeutics, Inc. 01 Nov 2021 0 $0 3 Director 03 Nov 2021, 16:45